Maria Nunez-Salces
Research Subjects
Research Interests
Maria Nunez-Salces has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Amanda J. Page
Adelaide University
5 shared publications Hui Li
Vagal Afferent Research Group Adelaide Medical School University of Adelaide Adelaide SA 5005 Australia
3 shared publications- Hui Li
Vagal Afferent Research Group, Australia; Centre of Research Excellence in Translating Nutritional Science to Good Health, Adelaide Medical School, The University of Adelaide, Adelaide, SA, 5005, Australia; Nutrition, Diabetes & Gut Health, Lifelong Health Theme, South Australian Health & Medical Research Institute (SAHMRI), Adelaide, SA, 5000, Australia
3 shared publications - Bo Lönnerdal
Department of Nutrition, University of California, Davis, CA 95616, USA
2 shared publications - Olle Hernell
Department of Clinical Sciences, Pediatrics, Umeå University, 901 87 Umeå, Sweden
2 shared publications - Richard L. Young
Intestinal Sensing Group, The University of Adelaide, Adelaide, SA 5005, Australia
2 shared publications
Latest Publications
- Open Access
Long-Term Effects on Growth and Hormonal Outcomes of Feeding Low-Protein Infant Formula Enriched with α-Lactalbumin or Reduced in Casein Glycomacropeptide During Early Infancy: A Follow-Up Study
Background: High protein intake during infancy has been associated with accelerated weight gain and increased risk of later obesity through insulin and insulin-like growth factor 1 (IGF-1) pathways. Objective: We aimed to investigate whether growth and metabolic outcomes closer to those of breastfed infants (BF) up to 12 months in the ALFoNS trial persisted during early childhood in children fed modified low-protein formulas (LPFs) during the first half of infancy compared to those fed standard formula (SF). Methods: In this randomized controlled trial (RCT), 245 formula-fed infants (FF) were randomized to SF (2.2 g protein/100 kcal) or one of two LPFs—either α-lactalbumin-enriched whey (α-lac-EW; 1.75 g protein/100 kcal) or casein glycomacropeptide-reduced whey (CGMP-RW; 1.76 g protein/100 kcal) between 2 and 6 months—with 83 BF infants as a non-randomized reference group. In the present study, children were followed up at 18, 36, and 60 months with assessment of anthropometry, nutrient intake and analyses of serum insulin, C-peptide, IGF-1 and hemoglobin at 18 months. Results: At 18 months, weight and body mass index (BMI) were significantly higher among SF compared with BF infants (p < 0.05), but with no differences between LPF groups and the BF group. The prevalence of overweight at 18 months was higher in the SF (0.014) and CGMP-RW (p = 0.016) groups, but not in α-lac-EW group (p = 0.054) compared with the BF group, while no significant differences were found between the FF groups. No differences in growth were observed between the groups at 36 or 60 months. Serum insulin, C-peptide, and IGF-1 did not differ significantly between the groups at 18 months. Conclusions: Feeding LPFs during early infancy was associated with growth patterns more similar to those of BF infants at 18 months of age, than if fed higher protein formula, but with no growth differences at 3 or 5 years.
Open AccessLong-Term Effects on Growth and Hormonal Outcomes of Feeding Low-Protein Infant Formula Enriched with α-Lactalbumin or Reduced in Casein Glycomacropeptide During Early Infancy: A Follow-Up Study
Background: High protein intake during infancy has been associated with accelerated weight gain and increased risk of later obesity through insulin and insulin-like growth factor 1 (IGF-1) pathways. Objective: We aimed to investigate whether growth and metabolic outcomes closer to those of breastfed infants (BF) up to 12 months in the ALFoNS trial persisted during early childhood in children fed modified low-protein formulas (LPFs) during the first half of infancy compared to those fed standard formula (SF). Methods: In this randomized controlled trial (RCT), 245 formula-fed infants (FF) were randomized to SF (2.2 g protein/100 kcal) or one of two LPFs—either α-lactalbumin-enriched whey (α-lac-EW; 1.75 g protein/100 kcal) or casein glycomacropeptide-reduced whey (CGMP-RW; 1.76 g protein/100 kcal) between 2 and 6 months—with 83 BF infants as a non-randomized reference group. In the present study, children were followed up at 18, 36, and 60 months with assessment of anthropometry, nutrient intake and analyses of serum insulin, C-peptide, IGF-1 and hemoglobin at 18 months. Results: At 18 months, weight and body mass index (BMI) were significantly higher among SF compared with BF infants (p < 0.05), but with no differences between LPF groups and the BF group. The prevalence of overweight at 18 months was higher in the SF (0.014) and CGMP-RW (p = 0.016) groups, but not in α-lac-EW group (p = 0.054) compared with the BF group, while no significant differences were found between the FF groups. No differences in growth were observed between the groups at 36 or 60 months. Serum insulin, C-peptide, and IGF-1 did not differ significantly between the groups at 18 months. Conclusions: Feeding LPFs during early infancy was associated with growth patterns more similar to those of BF infants at 18 months of age, than if fed higher protein formula, but with no growth differences at 3 or 5 years.
- Open Access
- 5 September 2025
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 81 (5) , 1296-1305
Immunological effects of alpha‐lactalbumin‐enriched low‐protein infant formula: A randomized controlled trial
Objectives: Breast‐fed (BF) have lower risk of infections during infancy compared to those formula‐fed (FF). A higher content of alpha‐lactalbumin (α‐lac) in breast milk, which may promote a more favorable gut microbiota, could be one reason. In this study, we evaluated whether increased concentration of α‐lac in low‐protein infant formula affects the immune response and the incidence of infections during infancy. Methods: In a double‐blinded randomized controlled trial, healthy‐term infants ( n = 245) received low‐protein infant formulas with α‐lac‐enriched whey (α‐lac‐EW; 1.75 g protein/100 kcal, 27% α‐lac) or casein glycomacropeptide‐reduced whey (CGMP‐RW; 1.76 g protein/100 kcal, 14% α‐lac), or standard formula (SF; 2.2 g protein/100 kcal, 10% α‐lac) from 2 to 6 months. BF constituted a reference group. Cytokines and high‐sensitivity C‐reactive protein (hsCRP) were measured during intervention and infection‐related morbidity, and treatment was evaluated until 12 months. Results: Serum interleukin‐6 (IL‐6) was lower in BF than in all FF groups during intervention ( p < 0.001). No other differences in cytokines (tumor necrosis factor alpha [TNF‐α], transforming growth factor beta 1 [TGF‐β1], TGF‐β2, IL‐1, IL‐10, IL‐12, interferon gamma [INF‐γ]) or hsCRP were found among the study groups. Infection‐related morbidity did not differ among study groups, except slight differences in the use of antibiotics during (α‐lac‐EW vs. CGMP‐RW [ p = 0.008]) and after intervention (α‐lac‐EW vs. BF [ p = 0.016]). Conclusions: Increased α‐lac concentration in low‐protein infant formula to levels similar to breast milk did not affect the cytokine profile and had minor effect on infection‐related morbidity. The higher IL‐6 concentrations in FF than in BF needs further investigation.
- 5 September 2025
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 81 (5) , 1296-1305
Open AccessImmunological effects of alpha‐lactalbumin‐enriched low‐protein infant formula: A randomized controlled trial
Objectives: Breast‐fed (BF) have lower risk of infections during infancy compared to those formula‐fed (FF). A higher content of alpha‐lactalbumin (α‐lac) in breast milk, which may promote a more favorable gut microbiota, could be one reason. In this study, we evaluated whether increased concentration of α‐lac in low‐protein infant formula affects the immune response and the incidence of infections during infancy. Methods: In a double‐blinded randomized controlled trial, healthy‐term infants ( n = 245) received low‐protein infant formulas with α‐lac‐enriched whey (α‐lac‐EW; 1.75 g protein/100 kcal, 27% α‐lac) or casein glycomacropeptide‐reduced whey (CGMP‐RW; 1.76 g protein/100 kcal, 14% α‐lac), or standard formula (SF; 2.2 g protein/100 kcal, 10% α‐lac) from 2 to 6 months. BF constituted a reference group. Cytokines and high‐sensitivity C‐reactive protein (hsCRP) were measured during intervention and infection‐related morbidity, and treatment was evaluated until 12 months. Results: Serum interleukin‐6 (IL‐6) was lower in BF than in all FF groups during intervention ( p < 0.001). No other differences in cytokines (tumor necrosis factor alpha [TNF‐α], transforming growth factor beta 1 [TGF‐β1], TGF‐β2, IL‐1, IL‐10, IL‐12, interferon gamma [INF‐γ]) or hsCRP were found among the study groups. Infection‐related morbidity did not differ among study groups, except slight differences in the use of antibiotics during (α‐lac‐EW vs. CGMP‐RW [ p = 0.008]) and after intervention (α‐lac‐EW vs. BF [ p = 0.016]). Conclusions: Increased α‐lac concentration in low‐protein infant formula to levels similar to breast milk did not affect the cytokine profile and had minor effect on infection‐related morbidity. The higher IL‐6 concentrations in FF than in BF needs further investigation.
- Open Access
The Effect of High-Fat Diet-Induced Obesity on the Expression of Nutrient Chemosensors in the Mouse Stomach and the Gastric Ghrelin Cell
The stomach is the primary source of the orexigenic and adiposity-promoting hormone, ghrelin. There is emerging evidence on the nutrient-mediated modulation of gastric ghrelin secretion. However, limited information is available on gastric nutrient-sensing mechanisms in high-fat diet (HFD)-induced obesity. This study investigated the impact of HFD-induced obesity on the expression of nutrient chemosensors in mouse stomach, particularly ghrelin cells. Male C57BL/6 mice were fed either a standard laboratory diet (SLD) or HFD for 12 weeks. The expression of ghrelin, enzymes involved in ghrelin production (PC1/3, GOAT) and nutrient chemosensors (CD36, FFAR2&4, GPR93, CaSR, mGluR4 and T1R3) was determined by quantitative RT-PCR in the mouse corpus and antrum. Immunohistochemistry assessed the protein expression of CaSR and ghrelin in the corpus and antrum. Antral mRNA levels of CaSR and PC1/3 were increased in HFD compared to SLD mice, while mRNA levels of all other nutrient chemosensors examined remained unchanged. CaSR immunolabelling was observed in the gastric antrum only. Nearly 80% of antral ghrelin cells expressed CaSR, with a similar cell density and co-expression in SLD and HFD mice. In conclusion, HFD-induced obesity increased CaSR mRNA expression in mouse antrum. However, the high antral co-expression of CaSR and ghrelin was unaltered in HFD compared to SLD mice.
Open AccessThe Effect of High-Fat Diet-Induced Obesity on the Expression of Nutrient Chemosensors in the Mouse Stomach and the Gastric Ghrelin Cell
The stomach is the primary source of the orexigenic and adiposity-promoting hormone, ghrelin. There is emerging evidence on the nutrient-mediated modulation of gastric ghrelin secretion. However, limited information is available on gastric nutrient-sensing mechanisms in high-fat diet (HFD)-induced obesity. This study investigated the impact of HFD-induced obesity on the expression of nutrient chemosensors in mouse stomach, particularly ghrelin cells. Male C57BL/6 mice were fed either a standard laboratory diet (SLD) or HFD for 12 weeks. The expression of ghrelin, enzymes involved in ghrelin production (PC1/3, GOAT) and nutrient chemosensors (CD36, FFAR2&4, GPR93, CaSR, mGluR4 and T1R3) was determined by quantitative RT-PCR in the mouse corpus and antrum. Immunohistochemistry assessed the protein expression of CaSR and ghrelin in the corpus and antrum. Antral mRNA levels of CaSR and PC1/3 were increased in HFD compared to SLD mice, while mRNA levels of all other nutrient chemosensors examined remained unchanged. CaSR immunolabelling was observed in the gastric antrum only. Nearly 80% of antral ghrelin cells expressed CaSR, with a similar cell density and co-expression in SLD and HFD mice. In conclusion, HFD-induced obesity increased CaSR mRNA expression in mouse antrum. However, the high antral co-expression of CaSR and ghrelin was unaltered in HFD compared to SLD mice.
- 14 July 2020
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 32 (12) , e13944
Nutrient‐sensing components of the mouse stomach and the gastric ghrelin cell
Background: The ability of the gut to detect nutrients is critical to the regulation of gut hormone secretion, food intake, and postprandial blood glucose control. Ingested nutrients are detected by specific gut chemosensors. However, knowledge of these chemosensors has primarily been derived from the intestine, while available information on gastric chemosensors is limited. This study aimed to investigate the nutrient‐sensing repertoire of the mouse stomach with particular emphasis on ghrelin cells.Methods: Quantitative RT‐PCR was used to determine mRNA levels of nutrient chemosensors (protein: G protein–coupled receptor 93 [GPR93], calcium‐sensing receptor [CaSR], metabotropic glutamate receptor type 4 [mGluR4]; fatty acids: CD36, FFAR2&4; sweet/umami taste: T1R3), taste transduction components (TRPM5, GNAT2&3), and ghrelin and ghrelin‐processing enzymes (PC1/3, ghrelin O‐acyltransferase [GOAT]) in the gastric corpus and antrum of adult male C57BL/6 mice. Immunohistochemistry was performed to assess protein expression of chemosensors (GPR93, T1R3, CD36, and FFAR4) and their co‐localization with ghrelin.Key Results: Most nutrient chemosensors had higher mRNA levels in the antrum compared to the corpus, except for CD36, GNAT2, ghrelin, and GOAT. Similar regional distribution was observed at the protein level. At least 60% of ghrelin‐positive cells expressed T1R3 and FFAR4, and over 80% expressed GPR93 and CD36.Conclusions and Inferences: The cellular mechanisms for the detection of nutrients are expressed in a region‐specific manner in the mouse stomach and gastric ghrelin cells. These gastric nutrient chemosensors may play a role modulating gastrointestinal responses, such as the inhibition of ghrelin secretion following food intake.
- 14 July 2020
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 32 (12) , e13944
Nutrient‐sensing components of the mouse stomach and the gastric ghrelin cell
Background: The ability of the gut to detect nutrients is critical to the regulation of gut hormone secretion, food intake, and postprandial blood glucose control. Ingested nutrients are detected by specific gut chemosensors. However, knowledge of these chemosensors has primarily been derived from the intestine, while available information on gastric chemosensors is limited. This study aimed to investigate the nutrient‐sensing repertoire of the mouse stomach with particular emphasis on ghrelin cells.Methods: Quantitative RT‐PCR was used to determine mRNA levels of nutrient chemosensors (protein: G protein–coupled receptor 93 [GPR93], calcium‐sensing receptor [CaSR], metabotropic glutamate receptor type 4 [mGluR4]; fatty acids: CD36, FFAR2&4; sweet/umami taste: T1R3), taste transduction components (TRPM5, GNAT2&3), and ghrelin and ghrelin‐processing enzymes (PC1/3, ghrelin O‐acyltransferase [GOAT]) in the gastric corpus and antrum of adult male C57BL/6 mice. Immunohistochemistry was performed to assess protein expression of chemosensors (GPR93, T1R3, CD36, and FFAR4) and their co‐localization with ghrelin.Key Results: Most nutrient chemosensors had higher mRNA levels in the antrum compared to the corpus, except for CD36, GNAT2, ghrelin, and GOAT. Similar regional distribution was observed at the protein level. At least 60% of ghrelin‐positive cells expressed T1R3 and FFAR4, and over 80% expressed GPR93 and CD36.Conclusions and Inferences: The cellular mechanisms for the detection of nutrients are expressed in a region‐specific manner in the mouse stomach and gastric ghrelin cells. These gastric nutrient chemosensors may play a role modulating gastrointestinal responses, such as the inhibition of ghrelin secretion following food intake.
- 1 May 2020
- Published by Wiley in The Journal of Physiology
- Vol. 598 (11) , 2169-2182
Modulatory effect of methanandamide on gastric vagal afferent satiety signals depends on nutritional status
Significance Statement: Gastric vagal afferent responses to tension are dampened in high fat diet‐induced obesity. Endocannabinoids are known to dose‐dependently inhibit and excite gastric vagal afferents but their effect on gastric vagal afferents in diet‐induced obesity are unknown. In individual gastric vagal afferent neurons of diet‐induced obese mice the co‐expression of components of the endocannabinoid system, including CB1, GHSR, TRPV1 and FAAH, was increased compared with lean mice. In high fat diet‐induced obese mice, methanandamide only inhibited gastric vagal afferent responses to tension, possibly due to the observed change in the balance of receptors, hormones and breakdown enzymes in this system. Collectively, these data suggest that endocannabinoid signalling, by gastric vagal afferents, is altered in diet‐induced obesity which may impact satiety and gastrointestinal function. Gastric vagal afferents (GVAs) play a role in appetite regulation. The endocannabinoid anandamide (AEA) dose‐dependently inhibits and excites tension‐sensitive GVAs. However, it is also known that high fat diet (HFD) feeding alters GVA responses to stretch. The aim of this study was to determine the role of AEA in GVA signalling in lean and HFD‐induced obese mice.Male C57BL/6 mice were fed (12 weeks) a standard laboratory diet (SLD) or HFD. Protein and mRNA expression of components of the cannabinoid system was determined in individual GVA cell bodies and the gastric mucosa. An in vitro GVA preparation was used to assess the effect of methanandamide (mAEA) on tension‐sensitive GVAs and the second messenger pathways involved.In individual GVA cell bodies, cannabinoid 1 (CB1) and ghrelin (GHSR) receptor mRNA was higher in HFD mice than SLD mice. Conversely, gastric mucosal AEA and ghrelin protein levels were lower in HFD mice than SLD mice. In SLD mice, mAEA exerted dose‐dependent inhibitory and excitatory effects on tension‐sensitive GVAs. Only an inhibitory effect of mAEA was observed in HFD mice. The excitatory effect of mAEA was dependent on CB1, transient receptor potential vanilloid 1 (TRPV1) and the protein kinase C. Conversely, the inhibitory effect was dependent on CB1, growth hormone secretagogue receptor, TRPV1 and the protein kinase A. Endocannabinoids, acting through CB1 and TRPV1, have a pivotal role in modulating GVA satiety signals depending on the second messenger pathway utilised. In HFD mice only an inhibitory effect was observed. These changes may contribute to the development and/or maintenance of obesity.
- 1 May 2020
- Published by Wiley in The Journal of Physiology
- Vol. 598 (11) , 2169-2182
Modulatory effect of methanandamide on gastric vagal afferent satiety signals depends on nutritional status
Significance Statement: Gastric vagal afferent responses to tension are dampened in high fat diet‐induced obesity. Endocannabinoids are known to dose‐dependently inhibit and excite gastric vagal afferents but their effect on gastric vagal afferents in diet‐induced obesity are unknown. In individual gastric vagal afferent neurons of diet‐induced obese mice the co‐expression of components of the endocannabinoid system, including CB1, GHSR, TRPV1 and FAAH, was increased compared with lean mice. In high fat diet‐induced obese mice, methanandamide only inhibited gastric vagal afferent responses to tension, possibly due to the observed change in the balance of receptors, hormones and breakdown enzymes in this system. Collectively, these data suggest that endocannabinoid signalling, by gastric vagal afferents, is altered in diet‐induced obesity which may impact satiety and gastrointestinal function. Gastric vagal afferents (GVAs) play a role in appetite regulation. The endocannabinoid anandamide (AEA) dose‐dependently inhibits and excites tension‐sensitive GVAs. However, it is also known that high fat diet (HFD) feeding alters GVA responses to stretch. The aim of this study was to determine the role of AEA in GVA signalling in lean and HFD‐induced obese mice.Male C57BL/6 mice were fed (12 weeks) a standard laboratory diet (SLD) or HFD. Protein and mRNA expression of components of the cannabinoid system was determined in individual GVA cell bodies and the gastric mucosa. An in vitro GVA preparation was used to assess the effect of methanandamide (mAEA) on tension‐sensitive GVAs and the second messenger pathways involved.In individual GVA cell bodies, cannabinoid 1 (CB1) and ghrelin (GHSR) receptor mRNA was higher in HFD mice than SLD mice. Conversely, gastric mucosal AEA and ghrelin protein levels were lower in HFD mice than SLD mice. In SLD mice, mAEA exerted dose‐dependent inhibitory and excitatory effects on tension‐sensitive GVAs. Only an inhibitory effect of mAEA was observed in HFD mice. The excitatory effect of mAEA was dependent on CB1, transient receptor potential vanilloid 1 (TRPV1) and the protein kinase C. Conversely, the inhibitory effect was dependent on CB1, growth hormone secretagogue receptor, TRPV1 and the protein kinase A. Endocannabinoids, acting through CB1 and TRPV1, have a pivotal role in modulating GVA satiety signals depending on the second messenger pathway utilised. In HFD mice only an inhibitory effect was observed. These changes may contribute to the development and/or maintenance of obesity.
- 1 May 2020
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 245 (2) , 327-342
Pregnancy, but not dietary octanoic acid supplementation, stimulates the ghrelin-pituitary growth hormone axis in mice
Circulating growth hormone (GH) concentrations increase during pregnancy in mice and remain pituitary-derived. Whether abundance or activation of the GH secretagogue ghrelin increase during pregnancy, or in response to dietary octanoic acid supplementation, is unclear. We therefore measured circulating GH profiles in late pregnant C57BL/6J mice and in aged-matched non-pregnant females fed with standard laboratory chow supplemented with 5% octanoic or palmitic (control) acid (n = 4–13/group). Serum total and acyl-ghrelin concentrations, stomach and placenta ghrelin mRNA and protein expression, Pcsk1 (encoding prohormone convertase 1/3) and Mboat4 (membrane bound O-acyl transferase 4) mRNA were determined at zeitgeber (ZT) 13 and ZT23. Total and basal GH secretion were higher in late pregnant than non-pregnant mice (P < 0.001), regardless of diet. At ZT13, serum concentrations of total ghrelin (P = 0.004), but not acyl-ghrelin, and the density of ghrelin-positive cells in the gastric antrum (P = 0.019) were higher, and gastric Mboat4 and Pcsk1 mRNA expression were lower in pregnant than non-pregnant mice at ZT23. In the placenta, ghrelin protein was localised mostly to labyrinthine trophoblast cells. Serum acyl-, but not total, ghrelin was lower at mid-pregnancy than in non-pregnant mice, but not different at early or late pregnancy. In conclusion, dietary supplementation with 5% octanoic acid did not increase activation of ghrelin in female mice. Our results further suggest that increases in maternal GH secretion throughout murine pregnancy are not due to circulating acyl-ghrelin acting at the pituitary. Nevertheless, time-dependent increased circulating total ghrelin could potentially increase ghrelin action in tissues that express the acylating enzyme and receptor.
- 1 May 2020
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 245 (2) , 327-342
Pregnancy, but not dietary octanoic acid supplementation, stimulates the ghrelin-pituitary growth hormone axis in mice
Circulating growth hormone (GH) concentrations increase during pregnancy in mice and remain pituitary-derived. Whether abundance or activation of the GH secretagogue ghrelin increase during pregnancy, or in response to dietary octanoic acid supplementation, is unclear. We therefore measured circulating GH profiles in late pregnant C57BL/6J mice and in aged-matched non-pregnant females fed with standard laboratory chow supplemented with 5% octanoic or palmitic (control) acid (n = 4–13/group). Serum total and acyl-ghrelin concentrations, stomach and placenta ghrelin mRNA and protein expression, Pcsk1 (encoding prohormone convertase 1/3) and Mboat4 (membrane bound O-acyl transferase 4) mRNA were determined at zeitgeber (ZT) 13 and ZT23. Total and basal GH secretion were higher in late pregnant than non-pregnant mice (P < 0.001), regardless of diet. At ZT13, serum concentrations of total ghrelin (P = 0.004), but not acyl-ghrelin, and the density of ghrelin-positive cells in the gastric antrum (P = 0.019) were higher, and gastric Mboat4 and Pcsk1 mRNA expression were lower in pregnant than non-pregnant mice at ZT23. In the placenta, ghrelin protein was localised mostly to labyrinthine trophoblast cells. Serum acyl-, but not total, ghrelin was lower at mid-pregnancy than in non-pregnant mice, but not different at early or late pregnancy. In conclusion, dietary supplementation with 5% octanoic acid did not increase activation of ghrelin in female mice. Our results further suggest that increases in maternal GH secretion throughout murine pregnancy are not due to circulating acyl-ghrelin acting at the pituitary. Nevertheless, time-dependent increased circulating total ghrelin could potentially increase ghrelin action in tissues that express the acylating enzyme and receptor.
- 26 June 2019
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 31 (12) , e13669
Chronic stress induces hypersensitivity of murine gastric vagal afferents
Background: Stress exposure is known to trigger and exacerbate functional dyspepsia (FD) symptoms. Increased gastric sensitivity to food‐related stimuli is widely observed in FD patients and is associated with stress and psychological disorders. The mechanisms underlying the hypersensitivity are not clear. Gastric vagal afferents (GVAs) play an important role in sensing meal‐related mechanical stimulation to modulate gastrointestinal function and food intake. This study aimed to determine whether GVAs display hypersensitivity after chronic stress, and whether its interaction with leptin was altered by stress.Methods: Eight‐week‐old male C57BL/6 mice were exposed to unpredictable chronic mild stress or no stress (control) for 8 weeks. The metabolic rate, gastric emptying rate, and anxiety‐ and depression‐like behaviors were determined. GVA mechanosensitivity, and its modulation by leptin, was determined using an in vitro single fiber recording technique. QRT‐PCR was used to establish the levels of leptin and leptin receptor mRNA in the stomach and nodose ganglion, respectively.Key Results: The stressed mice had lower body weight and food intake, and increased anxiety‐like behavior compared to the control mice. The mechanosensitivity of mucosal and tension‐sensitive GVAs was higher in the stressed mice. Leptin potentiated mucosal GVA mechanosensitivity in control but not stressed mice. The expression of leptin mRNA in the gastric mucosa was lower in the stressed mice.Conclusions and Inferences: In conclusion, chronic stress enhances GVA mechanosensitivity, which may contribute to the gastric hypersensitivity in FD. In addition, the modulatory effect of leptin on GVA signaling is lost after chronic stress exposure.
- 26 June 2019
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 31 (12) , e13669
Chronic stress induces hypersensitivity of murine gastric vagal afferents
Background: Stress exposure is known to trigger and exacerbate functional dyspepsia (FD) symptoms. Increased gastric sensitivity to food‐related stimuli is widely observed in FD patients and is associated with stress and psychological disorders. The mechanisms underlying the hypersensitivity are not clear. Gastric vagal afferents (GVAs) play an important role in sensing meal‐related mechanical stimulation to modulate gastrointestinal function and food intake. This study aimed to determine whether GVAs display hypersensitivity after chronic stress, and whether its interaction with leptin was altered by stress.Methods: Eight‐week‐old male C57BL/6 mice were exposed to unpredictable chronic mild stress or no stress (control) for 8 weeks. The metabolic rate, gastric emptying rate, and anxiety‐ and depression‐like behaviors were determined. GVA mechanosensitivity, and its modulation by leptin, was determined using an in vitro single fiber recording technique. QRT‐PCR was used to establish the levels of leptin and leptin receptor mRNA in the stomach and nodose ganglion, respectively.Key Results: The stressed mice had lower body weight and food intake, and increased anxiety‐like behavior compared to the control mice. The mechanosensitivity of mucosal and tension‐sensitive GVAs was higher in the stressed mice. Leptin potentiated mucosal GVA mechanosensitivity in control but not stressed mice. The expression of leptin mRNA in the gastric mucosa was lower in the stressed mice.Conclusions and Inferences: In conclusion, chronic stress enhances GVA mechanosensitivity, which may contribute to the gastric hypersensitivity in FD. In addition, the modulatory effect of leptin on GVA signaling is lost after chronic stress exposure.
- 1 May 2019
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 13 (3) , 289
Expression of nutrient sensing mechanisms in the mouse stomach
- 1 May 2019
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 13 (3) , 289
Expression of nutrient sensing mechanisms in the mouse stomach